1. Introduction {#sec1-marinedrugs-15-00128}
===============

Marine microorganisms are being explored as potentially important sources of environmentally friendly antifouling (AF) compounds because they can be cultivated to produce diverse chemical compounds under optimal culture conditions \[[@B1-marinedrugs-15-00128]\]. Several potent antifouling compounds have been isolated from various microorganisms, including polyethers from the marine bacterium *Winogradskyella Poriferorum* \[[@B2-marinedrugs-15-00128]\], 12-methyltetradecanoid acid and butenolides from *Streptomyces* sp. UST040711-290 and *Streptomyces Albidoflavus* \[[@B3-marinedrugs-15-00128],[@B4-marinedrugs-15-00128]\], 3-chloro-2,5-dihydroxybenzyl alcohol from the marine fungus *Ampelomyces* sp. \[[@B5-marinedrugs-15-00128]\], and Diindol-3-ylmethanes from *Pseudovibrio Denitrificans* \[[@B6-marinedrugs-15-00128]\]. Of these compounds, butenolides are regarded as the most potent natural antifoulants \[[@B7-marinedrugs-15-00128]\]. The binding targets of the butenolide 5-octylfuran-2(5H)-one have been identified in the barnacle *Balanus* (=*Amphibalanus*) *amphitrite*, the bryozoan *Bugula neritina* and the marine bacterium *Vibrio* sp. UST020129-010 \[[@B8-marinedrugs-15-00128]\]. These studies clearly demonstrate that marine microbes are a promising source of effective antifouling compounds.

In the present study, we report 11 new depsides---thielavins W--Z, Z~1~--Z~7~ (**1**--**11**)---and four known thielavins ([Figure 1](#marinedrugs-15-00128-f001){ref-type="fig"})---thielavins A, H, J, and K (**12**--**15**) \[[@B9-marinedrugs-15-00128]\]---which we isolated from the marine-derived fungal strain *Thielavia* sp. UST030930-004, and we evaluated the antifouling activity of each against the barnacle *B. amphitrite* cyprids.

2. Results and Discussion {#sec2-marinedrugs-15-00128}
=========================

2.1. Identification of the Fungus {#sec2dot1-marinedrugs-15-00128}
---------------------------------

The internal transcribed spacer (ITS) sequence of the fungal isolate UST030930-004 (GenBank accession number KJ716558) had a similarity of 97% with *Thielavia terrestris* NRRL 8126 (CP003011), indicating that isolate UST030930-004 is a *Thielavia* sp. closely related to this taxon.

2.2. Structure Elucidation {#sec2dot2-marinedrugs-15-00128}
--------------------------

Fifteen compounds were isolated from the ethyl acetate extract of *Thielavia* sp. UST030930-004, including the 11 new compounds---thielavins W--Z (**1**--**4**) and thielavins Z~1~--Z~7~ (**5**--**11**)---together with 4 known compounds---thielavins A, H, J, and K (**12**--**15**). Their chemical structures were determined using MS, 1D- and 2D-NMR spectroscopy.

Compound **1** was isolated as a white amorphous powder. The positive HRESIMS provided \[M + H\]^+^ at *m*/*z* 511.1604, corresponding to a molecular formula of C~27~H~26~O~10~ (calcd. for C~27~H~27~O~10~ \[M + H\]^+^ 511.1599), and the UV spectrum revealed absorption at *λ*~max~ 218.1, 267.8, and 304.2 nm. The ^1^H, ^13^C-NMR ([Table 1](#marinedrugs-15-00128-t001){ref-type="table"}) and HSQC spectra of **1** indicated the presence of 6 methyl groups at *δ*~H~ 2.52 (3H, s), 2.40 (3H, s), 2.29 (3H, s), 2.06 (3H, s), 2.06 (3H, s), 1.99 (3H, s), 18 olefinic carbons, including fifteen quaternary carbons at *δ*~C~ 138.7, 165.4, 114.2, 149.5, 114.7, 131.8, 150.7, 116.5, 149.1, 120.8, 121.6, 141.0, 161.4, 160.8, and 107.6, and 3 tertiary carbons at *δ*~C~ 110.3, 100.6, 110.3. Three carbonyl signals were also observed at *δ*~C~ 172.0, 167.1, and 166.7. These data suggested that the compound is similar to thielavin H (13) \[[@B9-marinedrugs-15-00128]\]. The only difference between **1** and thielavin H was that one methyl group in thielavin H was absent in **1**. The structure of **1** was established based on HMBC correlations and in-source collision-induced dissociation (ISCID) fragment ions. The HMBC correlations observed from the methyl group *δ*~H~ 1.99 (3-Me) to *δ*~C~ 165.4 (C-2), 114.2 (C-3) and 149.5 (C-4), from *δ*~H~ 2.52 (6-Me) to *δ*~C~ 138.7 (C-1), 110.3 (C-5) and 114.7 (C-6), and from an olefinic proton *δ*~H~ 6.18 (H-5) to C-4 and C-6 indicated the presence of a 2,4-dioxygenated-3,6-dimethylbenzene substructure (A). The second substructure (B) was confirmed by long-range couplings from *δ*~H~ 2.06 (3′-Me) to *δ*~C~ 150.7 (C-2′), 116.5 (C-3′) and 149.1(C-4′), and from *δ*~H~ 2.06 (5′-Me) to *δ*~C~ 120.8 (C-5′), 121.6 (C-6′) and C-4′, and couplings from another methyl group *δ*~H~ 2.29 (6′-Me) to *δ*~C~ 131.8 (C-1′), C-5′ and C-6′. The HMBC correlations from *δ*~H~ 2.40 (6″-Me) to *δ*~C~ 141.0 (C-1″), 110.3 (C-5″) and 107.6 (C-6″), correlations from an olefinic proton *δ*~H~ 6.26 (H-3″) to *δ*~C~ 161.4 (C-2″), C-5″, and correlations from olefinic proton *δ*~H~ 6.26 (H-5″) to *δ*~C~ 100.6 (C-3″), 160.8 (C-4″) and C-6″, indicated the presence of a 2,4-dioxygenated-6-methylbenzene substructure (C). From the deduction above, the remaining three carbonyl groups can only be assigned to C-1, C-1′ and C-1″, and these carbonyl groups may be interchangeable as no HMBC correlations were observed ([Figure 2](#marinedrugs-15-00128-f002){ref-type="fig"}a). The positive ISCID MS/MS gave ion peaks at *m*/*z* 329.1, 151.0, 361.1 and 179.1, suggesting the absence of \[M − A\]^+^, \[M − A − B\]^+^, \[M − C + 2H\]^+^ and \[M − A − C + 2H\]^+^ fragments ([Figure 2](#marinedrugs-15-00128-f002){ref-type="fig"}b), indicating that the order of the substructures is A − B − C ([Figure 2](#marinedrugs-15-00128-f002){ref-type="fig"}b). Thus the structure of **1** was determined (shown in [Figure 1](#marinedrugs-15-00128-f001){ref-type="fig"}) and named thielavin W.

Comparison of the UV, NMR, HRESIMS and ISCID MS/MS data shows that compounds **2**--**10** have the same core structure as compound **1**. Their structures were determined using the procedure described for compound **1**, and named thielavins X--Z and Z~1~--Z~5~, respectively. All of the ^1^H and ^13^C-NMR assignments of the new compounds **2**--**10** are summarized in [Table 1](#marinedrugs-15-00128-t001){ref-type="table"}, [Table 2](#marinedrugs-15-00128-t002){ref-type="table"}, [Table 3](#marinedrugs-15-00128-t003){ref-type="table"} and [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Compound **11** was obtained as a white amorphous powder. Positive HRESIMS gave \[M + H\]^+^ as *m*/*z* 375.1464, and the molecular formula was established as C~20~H~22~O~7~ (calcd. for C~20~H~23~O~7~ \[M + H\]^+^ 375.1438). The maximum UV absorption occurred at *λ*~max~ 215.8, 276.1, and 308.9 nm, and the ^1^H NMR ([Table 3](#marinedrugs-15-00128-t003){ref-type="table"}) revealed the presence of 5 quaternary methyl signals \[*δ*~H~ 1.96 (3H, s), 1.96 (3H, s), 2.13 (3H, s), 1.97 (3H, s), and 2.54 (3H, s)\], 1 methoxy signal \[*δ*~H~ 3.83 (3H, s)\], and 1 olefinic proton signal \[*δ*~H~ 6.40 (1H, s)\]. The ^13^C-NMR and HSQC results ([Table 3](#marinedrugs-15-00128-t003){ref-type="table"}) indicated the presence of 12 olefinic carbons, including 11 quaternary carbons at *δ*~C~ 162.6, 161.0, 150.7, 148.5, 139.4, 132.1, 121.4, 120.1, 116.0, 108.6, and 102.7, 1 tertiary carbon at *δ*~C~ 111.0 and 2 carbonyl groups at *δ*~C~ 168.7 and 168.9. Based on these data, compound **11** was proposed as a thielavin derivative consisting of two hydroxybenzoic acid groups with a methyl ester terminus. HMBC revealed correlations ([Figure 2](#marinedrugs-15-00128-f002){ref-type="fig"}c) between *δ*~H~ 1.96 (3-Me) and *δ*~C~ 150.7 (C-2), 116.0 (C-3) and 148.5 (C-4), between *δ*~H~ 1.96 (s, 5-Me) and *δ*~C~ 120.1 (C-5), 121.4 (C-6), C-4, and between *δ*~H~ 2.13 (6-Me) to *δ*~C~ 132.1 (C-1), C-5 and C-6, and also revealed long range correlations between *δ*~H~ 3.83 (1-COO[Me]{.ul}) and *δ*~C~ 168.7 (1-C=O). NOESY results show the correlation from protons 6-Me to methoxy proton (1-COO[Me]{.ul}), indicating the presence of a 2-hydroxyl-4-oxygenated-3,5,6-trimethylbenzoic methyl ester subunit, corresponding to the ion fragment of *m*/*z* 179.1. The HMBC correlations ([Figure 2](#marinedrugs-15-00128-f002){ref-type="fig"}c) from *δ*~H~ 1.97 (3′-Me) to *δ*~C~ 162.6 (C-2′), 108.6 (C-3′) and 161.0 (C-4′), from *δ*~H~ 6.40 (H-5′) to *δ*~C~ 102.7 (C-6′), 24.0 (6′-Me), C-3′ and C-4′, and from *δ*~H~ 2.54 (6′-Me) to *δ*~C~ 139.4 (C-1′), 111.0 (C-5′) and C-6′, suggested the presence of a 2-hydroxyl-4-oxygenated-3,6-dimethylbenzoyl subunit, corresponding to an ion fragment with *m*/*z* 211.1 ([Figure 2](#marinedrugs-15-00128-f002){ref-type="fig"}d). These two units should be connected by an ester bond, but there was no correlation between the two units and the connection was only supported by ion fragments \[M − B + 2H\]^+^, \[M -- Ome − B + H\]^+^ and \[M -- Ome − A\]^+^ at *m*/*z* 211.1, 179.1 and 165.1, respectively. Thus, the structure of 11 was determined (shown in [Figure 1](#marinedrugs-15-00128-f001){ref-type="fig"}**)** and named thielavin Z~7~.

Compounds **12**--**15** were identified as thielavin A (**12**), thielavin H (**13**), thielavin J (**14**), and thielavin K (**15**), by comparison of their spectral data with those reported in the literature \[[@B9-marinedrugs-15-00128],[@B10-marinedrugs-15-00128]\].

2.3. Anti-Larval Settlement and Recovery Activities {#sec2dot3-marinedrugs-15-00128}
---------------------------------------------------

The anti-larval settlement activities of compounds **1**--**15** against cyprid larvae of *B. amphitrite* are summarized in [Table 5](#marinedrugs-15-00128-t005){ref-type="table"}. Compounds **1**--**3** and compounds **6**--**13** deterred larval settlement ([Figure 3](#marinedrugs-15-00128-f003){ref-type="fig"}a). Due to the poor solubility of this group of compounds, we could not determine the LC~50~ values. Compounds **1**--**3**, **7**, and **11** also showed narcotic effects against cyprids of *B. amphitrite* at a concentration of 10 μM. Many organic molecules cause narcosis in barnacle larvae \[[@B11-marinedrugs-15-00128],[@B12-marinedrugs-15-00128]\]. With increasing concentrations of active thielavins, cyprids lost their phototactic response, showed reduced appendage activity and were completely immobilized at a concentration of 10 μM. However, when the cyprids were transferred into 0.22 μM filtered seawater FSW following exposure to thielavins for 24 h, some recovered quickly from the chemical shock and completed their attachment and metamorphosis. The recovery rates of cyprids treated with 10 μM of compounds **1**--**3**, **7** and **11** demonstrated that larvae had the highest recovery rate from treatment with compound **1**, while no larvae recovered from treatment with compound **11** for 24 h ([Figure 3](#marinedrugs-15-00128-f003){ref-type="fig"}b). Of all of the compounds, compound **1** showed excellent antifouling activity, and cyprids treated with this compound had the highest recovery rate. Thus, compound **1** is a promising natural antifoulant.

3. Materials and Methods {#sec3-marinedrugs-15-00128}
========================

3.1. General Experimental Procedure {#sec3dot1-marinedrugs-15-00128}
-----------------------------------

^1^H/^13^C and 2D-NMR spectral data were obtained using Varian Inova 500 MHz NMR spectrometers (Varian, Palo Alto, CA, USA). High-resolution mass spectra were acquired from UPLC-TOF-MS. The UPLC system was a Waters ACQUITY UPLC system (Waters, Manchester, UK) equipped with 150 mm × 2.1 mm Waters Acquity BEH C18 1.7-μm UPLC column and coupled to a Bruker micrOTOF-Q II mass spectrometer (Brucker Daltonics GmbH, Bremen, Germany). UV spectra were measured with a Shimadzu UV-2600 UV--vis spectrophotometer (Shimadzu, Kyoto, Japan) in an ACN solution. Semi-preparative reversed-phase HPLC was performed on a Waters 2695 liquid chromatography (Waters, Milford, CT, USA) with Luna C18(2) column (250 mm × 10 mm, 5 μm 100 Å, Phenomenex, Torrance, CA, USA). Column chromatography was performed on Rp-18 silica gel (Merck, Darmstadt, Germany).

3.2. Isolation and Identification of the Fungus {#sec3dot2-marinedrugs-15-00128}
-----------------------------------------------

The fungal strain UST030930-004 was isolated from 12-d biofilms developed at the pier of the Hong Kong University of Science and Technology (Hong Kong, China) in Port Shelter. The biofilms were developed on polystyrene dishes submerged in seawater for 12 days in September 2003 and scraped from the dishes using a sterile glass coverslip. The scraped samples were suspended in 1 mL and 10 mL of autoclaved Ringer solution separately. For each sample, 200 μL of the mixture was spread on a Corn Meal Agar plate (Oxoid Ltd. Hampshire, UK) containing the antibiotics streptomycin and penicillin (final concentrations of 100 and 50 mg·L^−1^) to inhibit bacterial contamination. These plates were incubated at 27 °C for 7 to 14 days. The hyphal tip was transferred to new agar plates, incubated at 27 °C, and replated until a pure culture was obtained.

The total genomic DNA of the fungal isolate UST030930-004 was extracted as described by Lai et al. \[[@B13-marinedrugs-15-00128]\], and the internal transcribed spacer (ITS) gene sequences were amplified by the polymerase chain reaction (PCR) using primers ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-TCCTCCGCTTATTGAT ATGC-3′). The ITS region was sequenced and compared with reference sequences in GenBank by BLAST search, showing a similarity of 97% with *Thielavia terrestris* NRRL 8126 (CP003011). The ITS sequence of the fungal isolate UST030930-004 has been submitted to GenBank (Accession no. KJ716558). The fungal strain UST030930-004 was deposited in the China Center for Type Culture Collection (CCTCC) as CCTCC AF 2014015.

3.3. Fermentation, Bioassay-Guided Isolation, and Purification {#sec3dot3-marinedrugs-15-00128}
--------------------------------------------------------------

The fungal strain UST030930-004 was cultured in a liquid medium containing 24 g·L^−1^ of potato-dextrose broth (Difco Laboratories, Detroit, MI, USA) and 20 g·L^−1^ of sea salts. Seed cultures were prepared in 50-mL Falcon tubes (BD Labware, Bedford, MA, USA), each containing 25 mL of medium, and cultivated at 23 °C for 3 days with shaking at 160 rpms. Afterwards, 2.8 L flasks, each containing 1.0 L of the same medium, were used for large-scale fermentation (16 L) with the following conditions: inoculation volume 5% (*v*/*v*), temperature 23 °C, rotation speed 160 rpms and a duration of 10 days on a shaker. The culture was filtered through 8 layers of cheesecloth to separate the filtrate and mycelia, which were treated separately. The filtrate was extracted with an equal volume of ethyl acetate (EA) three times, while the mycelial pellet was suspended in 80% acetone and sonicated using an ultrasonicator (Branson B-12, Danbury, CT, USA). The wet residue obtained after rotary evaporation to remove acetone was partitioned with EA. The filtrate and mycelial EA extracts were combined and evaporated in vacuo at 35 °C to dryness. The EA extract (22.0 g) was subjected to reversed-phase C18 flash chromatography and then eluted with solvents using a step gradient of H~2~O-MeOH to obtain fractions 1--5 (Fr. 1--5). Fr. 1--5 were tested for anti-larval settlement activity against *Balanus amphitrite*, and those showing potential activity were further purified. Fr. 3 was purified using semi-preparative HPLC (Phenomenex Luna C18 (2) 250 × 10 mm column) with MeOH/H~2~O (63:37, *v*/*v*) containing 5 mM ammonium acetate at the flow rate of 3 mL/min. In total, we obtained pure compounds **1** (2.4 mg), **2** (2.4 mg), **3** (3.9 mg), **4** (1.6 mg), **5** (4.2 mg), **6** (3.6 mg)**, 7** (2.0 mg), **8** (1.6 mg), **9** (0.8 mg), **10** (0.7 mg), **11** (0.7 mg), **12** (3.6 mg), **13** (4.4 mg), **14** (6.9 mg) and **15** (2.3 mg).

3.4. Spectral Data {#sec3dot4-marinedrugs-15-00128}
------------------

Thielavin W (**1**): White powder, UV ACN *λ*~max~ 218.1, 267.8, 304.2 nm; ^1^H and ^13^C-NMR data, see [Table 1](#marinedrugs-15-00128-t001){ref-type="table"}; HRESIMS *m*/*z* 511.1604 \[M + H\]^+^ (calcd. for C~27~H~27~O~10~ 511.1599); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin X (**2**): White powder, UV ACN *λ*~max~ 218.1, 267.8, 306.5 nm; ^1^H and ^13^C-NMR data, see [Table 1](#marinedrugs-15-00128-t001){ref-type="table"}; HRESIMS *m*/*z* 525.1727 \[M + H\]^+^ (calcd. for C~28~H~29~O~10~ 525.1755); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Y (**3**): White powder, UV ACN *λ*~max~ 218.1, 276.1, 304.7 nm; ^1^H and ^13^C-NMR data, see [Table 1](#marinedrugs-15-00128-t001){ref-type="table"}; HRESIMS *m*/*z* 525.1765 \[M + H\]^+^ (calcd. for C~28~H~29~O~10~ 525.1755); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Z (**4**): White powder, UV ACN *λ*~max~ 218.1, 276.1, 306.5 nm; ^1^H and ^13^C-NMR data, see [Table 1](#marinedrugs-15-00128-t001){ref-type="table"}; HRESIMS *m*/*z* 525.1757 \[M + H\]^+^ (calcd. For C~28~H~29~O~10~ 525.1755); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Z~1~ (**5**): White powder, UV ACN *λ*~max~ 218.1, 276.1, 306.9 nm; ^1^H and ^13^C-NMR data, see [Table 2](#marinedrugs-15-00128-t002){ref-type="table"}; HRESIMS *m*/*z* 525.1747 \[M + H\]^+^ (calcd. for C~28~H~29~O~10~ 525.1755); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Z~2~ (**6**): White powder, UV ACN *λ*~max~ 218.1, 267.8, 305.2 nm; ^1^H and ^13^C-NMR data, see [Table 2](#marinedrugs-15-00128-t002){ref-type="table"}; HRESIMS *m*/*z* 539.1916 \[M + H\]^+^ (calcd. for C~29~H~31~O~10~ 539.1912); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Z~3~ (**7**): White powder, UV ACN *λ*~max~ 214.6, 276.1, 309.1 nm; ^1^H and ^13^C-NMR data, see [Table 2](#marinedrugs-15-00128-t002){ref-type="table"}; HRESIMS *m*/*z* 525.1758 \[M + H\]^+^ (calcd. for C~28~H~29~O~10~ 525.1755); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Z~4~ (**8**): White powder, UV ACN *λ*~max~ 218.1, 267.8, 305.2 nm; ^1^H and ^13^C-NMR data, see [Table 2](#marinedrugs-15-00128-t002){ref-type="table"}; HRESIMS *m*/*z* 511.1564 \[M + H\]^+^ (calcd. for C~27~H~27~O~10~ 511.1599); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Z~5~ (**9**): White powder, UV ACN *λ*~max~ 213.4, 267.8, 307.0 nm; ^1^H and ^13^C-NMR data, see [Table 3](#marinedrugs-15-00128-t003){ref-type="table"}; HRESIMS *m*/*z* 525.1778 \[M + H\]^+^ (calcd. for C~28~H~29~O~10~ 525.1755); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Z~6~ (**10**): White powder, UV ACN *λ*~max~ 215.8, 276.1, 307.0 nm; ^1^H and ^13^C-NMR data, see [Table 3](#marinedrugs-15-00128-t003){ref-type="table"}; HRESIMS *m*/*z* 587.1719/589.1646 \[M + H\]^+^ 3:1 (calcd. for C~30~H~32~ClO~10~ 587.1679); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

Thielavin Z~7~ (**11**): White powder, UV ACN *λ*~max~ 215.8, 276.1, 308.9 nm; ^1^H and ^13^C-NMR data, see [Table 3](#marinedrugs-15-00128-t003){ref-type="table"}; HRESIMS *m*/*z* 375.1464 \[M + H\]^+^ (calcd. for C~20~H~23~O~7~ 375.1438); ISCID data, see [Table 4](#marinedrugs-15-00128-t004){ref-type="table"}.

3.5. Anti-Larval Settlement and Larval Recovery Assay {#sec3dot5-marinedrugs-15-00128}
-----------------------------------------------------

To prepare the larval culture of the barnacle *B. amphitrite*, adult brood stocks of *B. amphitrite* were collected from piling at the Pak Sha Wan Pier, Hong Kong (22°36′ N, 114°25′ E). Barnacle larvae were obtained and reared to cyprid stage as previously described by Harder et al. \[[@B14-marinedrugs-15-00128]\]. The cyprids were filtered and maintained in (FSW) at 4 °C overnight, before being used in the settlement assay. A stock solution of each extract or purified compound was prepared at 50 mg·mL^−1^ in dimethyl sulfoxide (DMSO) and further diluted to varying concentrations (25, 12.5, 6.25, 3.125, 1.562, 0.781 mg·mL^−1^) immediately before each bioassay. One milliliter of the test solutions was added to each well of a 24-well plate (Nunc, Thermo Scientific, Rochester, NY, USA), and approximately 15 larvae were gently pipetted into each well. For the negative controls, 1.0 mL of FSW together with 1.0 μL of DMSO, instead of the testing solution, was added to each well prior to the addition of larvae. The plates were incubated at 28 °C for 48 h in the dark. At the end of the incubation, the numbers of settled and swimming larvae were counted directly under a microscope, and where appropriate, potential toxic effects were noted. The number of settled larvae was expressed as a percentage of the total number of larvae per well. Three replicates of each extract concentration or purified compound were evaluated. EC~50~ represents the concentration of a compound that inhibits settlement of 50% of the larval population compared with the negative control, while the LC~50~ represents the concentration of a compound that is required to kill 50% of the larvae in a tested population. The experiments were performed in triplicate.

In the recovery assay, cyprids used in the negative controls were placed in new polypropylene containers containing FSW for 24 h, as described in the literature \[[@B15-marinedrugs-15-00128]\]. One milliliter of 10 μM of the test solutions was added to each well of a 24-well plate, and approximately 15 larvae were added to each well. After a 24-h incubation at 28 °C in the dark, the tested solutions were removed, and the treated larvae were washed 3 times with FSW prior to being plated in a new 24-well plate. For the negative controls, swimming larvae in a polypropylene container were transferred to 1.0 mL of FSW containing 1.0 μL of DMSO. The plates were maintained at 28 °C for 48 h before determining the percentage of attached cyprids of *B. amphitrite*. Three replicates of each experimental concentration were assessed.

4. Conclusions {#sec4-marinedrugs-15-00128}
==============

Thielavins are para-depside-type compounds originally isolated from *Thielavia terricola* \[[@B10-marinedrugs-15-00128]\]. To date, 23 thielavins (thielavin A--V) have been discovered, including two thielavin Qs \[[@B16-marinedrugs-15-00128],[@B17-marinedrugs-15-00128],[@B18-marinedrugs-15-00128]\]. The thielavins act as indoleamine 2,3-dioxygenase, prostaglandin synthetase, glucose-6-phosphatase, cell wall transglycosylation and telomerase inhibitors \[[@B9-marinedrugs-15-00128],[@B10-marinedrugs-15-00128],[@B16-marinedrugs-15-00128],[@B19-marinedrugs-15-00128],[@B20-marinedrugs-15-00128]\]. We have not found any description of the antifouling activity of thielavin compounds. In the present study, we isolated 15 thielavins from a marine-derived fungus *Thielavia* sp. UST030930-004, including 11 new ones, and 11 of them had antifouling activities. Of all of the compounds, Thielavin W (**1**) showed excellent antifouling activity, and cyprids treated with this compound had the highest recovery rate. Thus, Thielavin W is a promising natural antifoulant.
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![Structures of compounds **1**--**15**.](marinedrugs-15-00128-g001){#marinedrugs-15-00128-f001}

![(**a**) Key HMBC and NOESY correlations; (**b**) ESIMS in-source fragmentation of compound **1**; (**c**) Key HMBC and NOESY correlations; (**d**) ESIMS in-source fragmentation of compound **11**.](marinedrugs-15-00128-g002){#marinedrugs-15-00128-f002}

![(**a**) EC~50~ of thielavin compounds against cyprids of *Balanus amphitrite*; Butenolide served as a positive control. (**b**) Recovery of *Balanus amphitrite* cyprid settlement in filtered seawater after a 24 h treatment with 10 μM of the thielavins we identified. The results were observed 48 h after being removed to filtered seawater. Values are presented as means ± SE of triplicate experiments. Asterisks indicate significant differences from control using Tukey's test (\* *p* \< 0.05, \*\* *p* \< 0.01, oneway ANOVA).](marinedrugs-15-00128-g003){#marinedrugs-15-00128-f003}
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###### 

The ^1^H (500 MHz) and ^13^C-NMR (125 MHz) NMR data for compounds **1**--**4** (*δ* in ppm, DMSO-*d*~6~).

  Position   1        2          3        4                                           
  ---------- -------- ---------- -------- ---------- ------------ ---------- -------- ----------
  1                   138.7               139.0                   142.1               138.7
  2                   165.4               164.8                   161.2               165.1
  3                   114.2               114.3      6.36 d 2.0   107.0               114.4
  4                   149.5               150.8                   151.5               149.8
  5          6.18 s   110.3      6.21 s   111.2      6.29 d 2.0   111.3      6.41 s   111.3
  6                   114.7               115.5                   117.5               115.3
  1′                  131.8               132.2                   132.4               135.5
  2′                  150.7               153.2                   153.2               154.5
  3′                  116.5               121.8                   121.6      7.01 s   104.2
  4′                  149.1               149.5                   148.9               149.9
  5′                  120.8               125.8                   125.6               121.2
  6′                  121.6               126.2                   126.4               121.7
  1″                  141.0               141.0                   139.5               139.3
  2″                  161.4               161.4                   162.7               162.2
  3″         6.26 s   100.6      6.27 s   100.6                   108.7               114.4
  4″                  160.8               160.6                   160.6               160.9
  5″         6.26 s   110.3      6.27 s   110.2      6.44 s       111.3      6.14 s   111.3
  6″                  107.6               107.2                   102.8               103.5
  1-C=O               172.0 \*            172.5 \*                170.7 \*            171.9 \*
  2-OMe                                                                               
  3-Me       1.99 s   9.4        1.99 s   9.0                                1.98 s   8.1
  5-Me                                                                                
  6-Me       2.52 s   23.1       2.40 s   23.0       2.56 s       24.1       2.55 s   23.8
  1′-C=O              167.1 \*            166.9 \*                169.3 \*            169.7 \*
  2′-OMe                         3.78 s   62.0       3.79 s       62.0       3.82 s   56.3
  3′-Me      2.06 s   10.2       2.13 s   10.0       2.08 s       9.9                 
  5′-Me      2.06 s   12.5       2.12 s   12.7       2.06 s       12.6       2.03 s   12.0
  6′-Me      2.29 s   16.7       2.31 s   16.6       2.29 s       16.5       2.32 s   16.8
  1″-C=O              166.7 \*            165.9 \*                165.9 \*            165.7 \*
  3″-Me                                              1.99 s       8.1        1.96 s   9.1
  5″-Me                                                                               
  6″-Me      2.40 s   21.8       2.54 s   21.8       2.55 s       21.8       2.52 s   23.1

NMR assignments marked by an asterisk (\*) are interchangeable.

marinedrugs-15-00128-t002_Table 2

###### 

The ^1^H (500 MHz) and ^13^C-NMR (125 MHz) NMR data for compounds **5**--**8** (*δ* in ppm, DMSO-*d*~6~).

  Position   5        6          7        8                                           
  ---------- -------- ---------- -------- ---------- -------- ---------- ------------ ----------
  1                   139.1               139.1               138.9                   138.9
  2                   156.2               156.7               162.0                   165.2
  3                   115.4               115.4               116.5                   114.2
  4                   151.0               150.7               151.7                   149.5
  5          6.40 s   113.2               118.6      6.64 s   115.8      6.16 s       109.8
  6                   114.1               120.4               112.1                   115.8
  1′                  134.3               134.8               132.0                   134.0
  2′                  156.2               156.2               150.7                   156.1
  3′                  122.0               122.2               116.5                   122.0
  4′                  150.6               149.3               148.8                   150.8
  5′         7.10 s   120.1      7.12 s   120.4               120.7      7.00 s       119.9
  6′                  125.7               125.4               121.7                   126.0
  1″                  139.1               139.1               139.5                   140.4
  2″                  162.0               162.0               162.7                   160.0
  3″                  108.6               108.6               108.6      6.25 d 2.0   100.7
  4″                  160.9               160.9               161.0                   161.1
  5″         6.40 s   111.1      6.41 s   111.0      6.42 s   111.2      6.24 d 2.0   109.9
  6″                  103.6               103.7               102.8                   108.3
  1-C=O               172.7 \*            171.5 \*            173.0 \*                171.7 \*
  2-OMe                                                                               
  3-Me       2.03 s   9.1        2.08 s   9.9                                         
  5-Me                           2.10 s   12.6       2.10 s   9.2        1.97 s       9.3
  6-Me       2.52 s   23.6       2.40 s   17.4                                        
  1′-C=O              169.4 \*            169.4 \*   2.50 s   22.9       2.53 s       23.1
  2′-OMe     3.82 s   61.9       3.79 s   61.9                169.5 \*                167 \*
  3′-Me      2.11 s   9.6        2.13 s   9.6                            3.81 s       62.0
  5′-Me                                              2.02 s   10.1       2.14 s       9.6
  6′-Me      2.4 s    18.7       2.40 s   19.2       2.01 s   12.4                    
  1″-C=O              165.1 \*            165.0 \*   2.30 s   16.7       2.39 s       18.6
  3″-Me      1.98 s   8.1        1.98 s   8.1                 166.4 \*                165.4 \*
  5″-Me                                              1.98 s   8.0                     
  6″-Me      2.52 s   23.0       2.53 s   23.6                                        

NMR assignments marked by an asterisk (\*) are interchangeable.

marinedrugs-15-00128-t003_Table 3

###### 

The ^1^H (500 MHz) and ^13^C-NMR (125 MHz) NMR data for compounds **9**--**11** (*δ* in ppm, DMSO-*d*~6~).

  Position   9        10         11                           
  ---------- -------- ---------- -------- ---------- -------- ----------
  1                   136.8               138.3               132.1
  2                   161.3               160.0               150.7
  3                   113.3               116.5               116.0
  4                   148.6               151.8               148.5
  5                   115.5               120.6               120.1
  6                   117.5               115.7               121.4
  1′                  134.5               134.1               139.4
  2′                  156.6               155.0               162.6
  3′                  122.2               122.7               108.6
  4′                  150.9               150.3               161.0
  5′         7.01 s   120.2               126.4      6.40 s   111.0
  6′                  125.7               127.5               102.7
  1″                  140.3               136.2               
  2″                  161.1               \* 160.8            
  3″         6.23 s   100.5               112.8               
  4″                  161.2               \* 157.9            
  5″         6.23 s   109.9               107.2               
  6″                  108.3               116.2               
  1-C=O               171.8 \*            UD                  168.7 \*
  1-COOMe                                            3.83 s   51.9
  2-OMe                                                       
  3-Me       2.01 s   9.8        2.62 s   9.6        1.96 s   9.7
  5-Me       2.04 s   12.5       2.42 s   12.6       1.96 s   12.3
  6-Me       2.58 s   17.4       2.84 s   17.8       2.13 s   16.6
  1′-C=O              167.1 \*            UD                  168.9
  2′-OMe     3.78 s   62.0       3.90 s   61.9                
  3′-Me      2.16 s   9.7        2.36 s   9.7        1.97 s   7.8
  5′-Me                          2.21 s   12.6                
  6′-Me      2.40 s   19.1       2.44 s   16.7       2.54 s   24.0
  1″-C=O              165.8 \*            UD                  
  3″-Me                          2.57 s   9.2                 
  5″-Me                                                       
  6″-Me      2.39 s   21.4       2.94 s   19.4                

NMR assignments marked by an asterisk (\*) are interchangeable. UD: undetected. ^13^C-NMR signals were not observed due to a limited amount of compound **10**.
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###### 

Physicochemical properties of new thielavins.

                                  1                 2                   3                 4
  ------------------------------- ----------------- ------------------- ----------------- -----------------
  Molecular Formula               C~27~H~27~O~10~   C~28~H~29~O~10~     C~28~H~29~O~10~   C~28~H~29~O~10~
  HRESIMS (pos) Obsd. (*m*/*z*)   511.1604          525.1727            525.1765          525.1757
  Cald. (*m*/*z*)                 511.1599          525.1755            525.1755          525.1755
  ISCID (*m*/*z*)                                   493.2               507.2             507.1
                                  361.1             375.2               361.1             361.1
                                  329.1             343.1               357.1             343.1
                                  179.1             193.1               193.1             179.1
                                  151.0             151.0               165.1             165.1
  UV                              218.1             218.1               218.1             218.1
                                  267.8             267.8               276.1             276.1
                                  304.2             306.5               304.7             306.5
                                  **5**             **6**               **7**             **8**
  Molecular Formula               C~28~H~29~O~10~   C~29~H~31~O~10~     C~28~H~29~O~10~   C~27~H~27~O~10~
  HRESIMS (pos) Obsd. (*m*/*z*)   525.1747          539.1916            525.1758          511.1564
  Cald. (*m*/*z*)                 525.1755          539.1912            525.1755          511.1599
  ISCID (*m*/*z*)                                   507.2                                 479.1
                                  361.1             375.2               361.1             361.1
                                  343.1             343.1               343.1             329.1
                                  179.1             179.1               179.1             179.1
                                  165.1             165.1               165.1             151.0
  UV                              218.1             218.1               214.6             218.1
                                  276.1             276.8               276.1             267.8
                                  306.9             305.2               309.1             305.2
                                  **9**             **10**              **11**            
  Molecular Formula               C~28~H~29~O~10~   C~30~H~32~ClO~10~   C~20~H~23~O~7~    
  HRESIMS (pos) Obsd. (*m*/*z*)   525.1778          587.1719/589.1646   375.1464          
  Cald. (*m*/*z*)                 525.1755          587.1679            375.1438          
  ISCID (*m*/*z*)                                   389.1                                 
                                  375.2             391.1/393.1                           
                                  329.1             199.0/201.0         211.1             
                                  179.1             193.1               179.1             
                                  151.0                                 165.1             
  UV                              213.4             215.8               215.8             
                                  267.8             276.1               276.1             
                                  307.0             307.0               308.9             

marinedrugs-15-00128-t005_Table 5

###### 

Anti-larval settlement activity of compounds from the fungus *Thielavia* sp. UST030930-004 against *Balanus amphitrite*. EC~50~ means the settlement of 50% of the larval population was inhibited, compared with the negative control. Data presented are the mean ± SE of three independent experiments performed in triplicate. Butenolide was served as the positive control.

  Compounds   EC~50~ (μM)    Compounds    EC~50~ (μM)
  ----------- -------------- ------------ --------------
  **1**       2.95 ± 0.59    **9**        25.86 ± 1.56
  **2**       3.13 ± 1.37    **10**       17.86 ± 3.14
  **3**       5.78 ± 0.60    **11**       3.20 ± 0.83
  **6**       69.19 ± 9.51   **12**       54.99 ± 5.23
  **7**       4.23 ± 1.30    **13**       12.64 ± 6.20
  **8**       50.50 ± 7.35   Butenolide   4.62 ± 1.30
